Prospective Research Assessment in Multiple Myeloma: An Observational Evaluation (PREAMBLE)

Prospective Research Assessment in Multiple Myeloma: An Observational Evaluation (PREAMBLE)

The purpose of this study is to assess the clinical effectiveness of all approved multiple myeloma (MM) therapies in the newly-diagnosed (NDMM) and the relapsed/refractory MM (RRMM) settings in real-world clinical practice.

Sponsor

Bristol-Myers Squibb

Multiple Locations

International Study

---

ClinicalTrials.gov Identifier: NCT01838512

Official Title: Prospective Research Assessment in Multiple Myeloma: An Observational Evaluation (PREAMBLE)

First Posted : April 24, 2013

Click here to see details on ClinicalTrials.gov